Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 05, 2026 10:14 ET | Source: Spherix Global Insights

Paroxysmal Nocturnal Hemoglobinuria Market Enters Transition Phase as Second-Line Opportunities Expand Amid Ongoing Barriers to Adoption of Newer Agents, According to Spherix Global Insights

Exton, PA, March 05, 2026 (GLOBE NEWSWIRE) -- Spherix Global Insights today announces the release of its latest Market Dynamix™: Paroxysmal Nocturnal Hemoglobinuria (PNH) (US) 2026 study, revealing...
March 05, 2026 10:14 ET | Source: Spherix Global Insights

Paroxysmal Nocturnal Hemoglobinuria Market Enters Transition Phase as Second-Line Opportunities Expand Amid Ongoing Barriers to Adoption of Newer Agents, According to Spherix Global Insights

Exton, PA, March 05, 2026 (GLOBE NEWSWIRE) -- Spherix Global Insights today announces the release of its latest Market Dynamix™: Paroxysmal Nocturnal Hemoglobinuria (PNH) (US) 2026 study, revealing...
October 28, 2024 13:00 ET | Source: DelveInsight Business Research LLP

Complement Inhibitors Clinical Trial Pipeline Analysis: 40+ Key Companies Shaping the Future of Complement Inhibitor Therapeutics | DelveInsight

New York, USA, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Complement Inhibitors Clinical Trial Pipeline Analysis: 40+ Key Companies Shaping the Future of Complement Inhibitor Therapeutics | DelveInsight ...
July 14, 2023 07:53 ET | Source: Zion Market Research

Revenue of Paroxysmal Nocturnal Hemoglobinuria Drug Market Size to Reach $8.9 Billion by 2030, Forecasted to Grow at 12.5% CAGR

Denver, CO, July 14, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Paroxysmal Nocturnal Hemoglobinuria Drug Market By Treatment (Medication, Supplements,...